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Adult Cardiac Stem Cells Are Multipotent
and Support Myocardial Regeneration
Evidence challenging the accepted wisdom has been
slowly accumulating (McDonnell and Oberpriller, 1984;
Rumyantsev and Broisov, 1987). In the past few years,
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Hideko Kasahara,2 Marcello Rota,1 Ezio Musso,1 we have documented the existence of cycling ventricu-
lar myocytes in the normal and pathologic adult mam-Konrad Urbanek,1 Annarosa Leri,1
Jan Kajstura,1 Bernardo Nadal-Ginard,1,* malian heart of several species, including humans (Kaj-
stura et al., 1998; Beltrami et al., 2001; Quaini et al.,and Piero Anversa1,*
1Cardiovascular Research Institute 2002). Although these data provided an alternative view
of cardiac homeostasis, they also raised questions be-Department of Medicine
New York Medical College cause it required reconciliation of two apparent contra-
dictory bodies of evidence: the well-documented irre-Valhalla, New York, 10595
2 Department of Physiology and Functional versible withdrawal of cardiac myocytes from the cell
cycle soon after birth on one hand (MacLellan andGenomics
University of Florida Schneider, 2000; Chien and Olson, 2002), and the pres-
ence of cycling myocytes undergoing mitosis and cyto-Gainesville, Florida 32611
kinesis on the other. These results raised the question as
to the origin of the cycling myocytes and their dramatic
increase in response to an acute work overload.Summary
In cases of sex-mismatched cardiac transplants in
humans, the female hearts in the male hosts had a signif-The notion of the adult heart as terminally differenti-
ated organ without self-renewal potential has been icant number of Y positive myocytes and coronary ves-
sels (Quaini et al., 2002). Most likely due to technicalundermined by the existence of a subpopulation of
replicating myocytes in normal and pathological differences (Anversa and Nadal-Ginard, 2002a), there
are some discrepancies among groups about the degreestates. The origin and significance of these cells has
remained obscure for lack of a proper biological con- of cardiac chimerism (Muller et al., 2002; Glaser et al.,
2002; Laflamme et al., 2002). It is likely that these maletext. We report the existence of Lin c-kitPOS cells with
the properties of cardiac stem cells. They are self- cells colonized the female heart after the transplant and
subsequently differentiated, although alternative expla-renewing, clonogenic, and multipotent, giving rise to
myocytes, smooth muscle, and endothelial cells. When nations have been raised. These male cells in the female
heart presuppose the existence of mobile stem-like cellsinjected into an ischemic heart, these cells or their
clonal progeny reconstitute well-differentiated myo- able to differentiate into the three main cardiac cell
types: myocytes, smooth, and endothelial vascular cells.cardium, formed by blood-carrying new vessels and
myocytes with the characteristics of young cells, en- Primitive cells of donor and recipient origin that ex-
press stem cell-related surface antigens—c-kit, Sca-1,compassing 70% of the ventricle. Thus, the adult
heart, like the brain, is mainly composed of terminally and MDR1—were identified in the recipient hearts. More
importantly, identical cells were found in human controldifferentiated cells, but is not a terminally differenti-
ated organ because it contains stem cells supporting hearts (Quaini et al., 2002; Anversa and Nadal-Ginard,
2002b). It is well known that in early fetal life, c-kitPOSits regeneration. The existence of these cells opens
new opportunities for myocardial repair. cells colonize the yolk sack, liver, and probably other
organs. The colonized organs express stem cell factor
(SCF), the ligand of the c-kit receptor (Teyssier-Le Dis-Introduction
corde et al., 1999); SCF mRNA is also present in fetal
and neonatal myocardium (Kunisada et al., 1998), raisingUntil recently, the accepted paradigm in cardiac biology
considered the adult mammalian heart to be a postmi- the possibility that stem-like cells could have been in
totic organ without regenerative capacity. It has been the heart from fetal life. The rapid induction of SCF
assumed that from shortly after birth to adulthood and during myocardial ischemia (Frangogiannis et al., 1998)
senescence the heart has a relatively stable but slowly could be involved in the activation of these cells and
diminishing number of myocytes. This static view of explain the significant increase in new myocyte forma-
the myocardium implied that both myocyte death and tion (Beltrami et al., 2001). However, the origin of these
myocyte regeneration had little role in cardiac cellular primitive cells, their presence in normal and pathological
homeostasis. Although stem cells have been isolated hearts, together with the identification of some of them
from many adult tissues including the blood, skin, cen- having initiated the cardiomyocyte gene expression pro-
tral nervous system, liver, gastrointestinal tract, and gram, is suggestive that they might be true cardiac stem
skeletal muscle (see Rosenthal, 2003), the search for a cells that give rise to the cycling myocytes detected in
cardiac stem cell has been considered futile given the the adult heart. If this were the case, their manipulation
accepted lack of regenerative potential of this tissue. might provide the opportunity to stimulate myocardial
regeneration with endogenous cells. For this reason, we
endeavored to establish a precursor-product relation-*Correspondence: piero_anversa@nymc.edu (P.A.), b_nadal-ginard@
nymc.edu (B.N.-G.) ship between these primitive cells and the fully differenti-
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ated cardiac cells and to determine, in vitro and in vivo,
whether they behave like true adult cardiac stem cells.
Results
Cells with the Characteristics of Myogenic
Stem/Progenitor Cells Are Present
in the Adult Myocardium
To determine whether the putative cardiac stem cells
detected in human heart transplants and their controls
are bona fide stem cells with cardiogenic potential, we
isolated them to test their differentiation potential in vivo
and in vitro. For experimental convenience, we chose
the rat as the animal model system. We first analyzed
whether cells with the cell surface markers commonly
expressed by other stem cells could be identified in the
adult rat myocardium. Based on the postulated higher
number of proliferating stem and precursor cells with
age (Morrison et al., 1996), we analyzed the myocardium
from older animals. Histological sections of myocardium
from Fisher rats 20–23 months of age were examined
by confocal microscopy for the presence of cells nega-
tive for the expression of blood lineage markers (Lin)
but positive for the common stem cell markers c-kit
(Kondo et al., 2003), Sca-1 (Morrison et al., 1997), and
MDR-1 (Sellers et al., 2001). Small Lin cells with a very
high nucleus/cytoplasm ratio and positive for each of
the above markers were distributed throughout the ven-
tricular and atrial myocardium with a higher density in
the atria and the ventricular apex. Because of the role
of bone marrow-derived Lin c-kitPOS cells in myocardial
regeneration (Orlic et al., 2001), the mesodermal origin
of both the heart and the bone marrow, and the use of
c-kit as a hematopoietic stem cell marker (Morrison et
Figure 1. Clusters of Primitive and Early Committed Cells in theal., 1997; Weissman et al., 2001; Kondo et al., 2003), we
Heartdecided to concentrate on the cardiac cells expressing
(A) Cluster of 11 c-kitPOS cells (green) with three expressing c-kitthis marker, the receptor for SCF. Although the density
only (arrows), seven expressing Nkx2.5 (white dots; arrowheads) inof these cells varied among different regions of the heart,
nuclei (blue, propidium iodide, PI), and 1 Nkx2.5 and -sarcomericon average we identified one Lin c-kitPOS cell every
actin in the cytoplasm (red; asterisk, see inset).
1  104 myocytes. It should be noted that most, if not (B) Cluster of 15 c-kitPOS cells with five c-kitPOS cells only (arrows),
all, of the detected c-kitPOS cells were negative for the eight expressing MEF2C (yellow dots; arrowheads), and one ex-
pressing MEF2C and -sarcomeric actin (asterisk, see inset). Bars,pan leukocyte marker CD45 and the endothelial/hema-
10 m.topoietic progenitor marker CD34.
As shown in Figures 1A and 1B, the Lin c-kitPOS cells
are found in small clusters in the intersticia between
cluster (see Figure 1), is strong evidence in support ofwell-differentiated myocytes and have an appearance
their cardiac myogenic potential and, most likely, of theircompatible with the clonal expansion of an activated
cardiac myogenic fate. That cells with similar character-primitive cell. Accordingly, many of these cells express
istics have also been identified in the mouse, dog, andKi67 (not shown), a marker for cells that either are or
pig (P.A., unpublished data), in addition to the humanhave recently been in the cell cycle (Scholzen and
(Quaini et al., 2002; Urbanek et al., 2003), is further indi-Gerdes, 2000). Many of these clusters contain cells at
cation of their likely biological significance.several early stages of cardiac myogenic differentiation,
as demonstrated by the expression of the transcription
factors GATA4, Nkx2.5, and MEF2, together with small Isolation and Characterization of Lin c-kitPOS
Cells from the Adult Myocardiumamounts of sarcomeric proteins in the cytoplasm.
This phenotype strongly suggests that these cell clus- Cardiac cells were isolated from female Fischer rats at
20–25 months of age. Small cells, containing most ofters represent amplifying myogenic precursors and/or
progenitors derived from the activation of a more-primi- the Lin c-kitPOS population, were separated from the
differentiated myocytes by differential centrifugationtive stem cell. The expression of transcription factors
associated with early cardiac development, such as and incubated with an anti-c-kit antibody, which recog-
nizes the N-terminal epitope located at the external as-GATA4 (Molkentin et al., 1997) and Nkx2.5 (Kasahara et
al., 1998), and particularly, the expression of cardiac- pect of the membrane (Broudy, 1997). The c-kitPOS cells
were separated either by repeated panning, using immu-specific sarcomeric proteins by some of the cells in each
Adult Cardiac Stem Cells and Cardiac Regeneration
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Figure 2. FACS Analysis and Culture of Lin c-kitPOS Cells
(A) Profiles of cells labeled with c-kit (red), secondary-antibody only (blue), and beads-c-kit (green). c-kitPOS cells were 7%  3% of purified
myocardial small cells.
(B) c-kitPOS cells isolated by FACS cultured in mNSCM: c-kit, green; PI, blue.
(C) Freshly isolated c-kitPOS cells with adherent beads. c-kit, green; beads, red; PI, blue.
(D–F) Smears of purified c-kitPOS cells (green) expressing Nkx2.5 ([D], white), MEF2C ([E], yellow), and GATA-4 ([F], magenta). PI, blue. Bars,
10 m.
nomagnetic microbeads or by FACS sorting (see Experi- ever, transcription factors expressed early in the
myocyte lineage (Nkx2.5, GATA-4, and MEF2) were eachmental Procedures). There was no appreciable differ-
ence between the cells isolated by these two methods, detected in 7%–10% of the freshly isolated c-kitPOS cells
(Figures 2D–2F), with occasional (0.5%) c-kitPOS cellseach resulting in 90% c-kitPOS cells (Figures 2A–2C).
With few exceptions, freshly isolated c-kitPOS cells expressing sarcomeric proteins, as would be expected
from their phenotype shown in Figure 1. These resultsscored negative for myocyte (-sarcomeric actin, car-
diac myosin, desmin, -cardiac actinin, and connexin further document that the c-kitPOS cell population is het-
erogeneous as to its stage of differentiation and that43), endothelial cell (EC; von Willebrand factor, CD31,
and vimentin), smooth muscle cell (SMC;-smooth mus- some of them are already committed to the cardiac
myogenic lineage. Skeletal muscle transcription factorscle actin and desmin), and fibroblast cytoplasmic pro-
teins (F; fibronectin, procollagen I, and vimentin). How- (MyoD, myogenin, and Myf5) were not detected in this
Cell
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population either by immunohistochemistry or Western To test the differentiation characteristics of these cells
in vitro, subconfluent cultures at different passagesblot analysis (see Supplemental Figures S1A–S1F online
ranging from P0–P23 were placed in differentiation me-at http://www.cell.com/cgi/content/full/114/6/763/DC1). It
dium (DM). 7–10 days later, many of the cells hadshould be noted that, despite that isolation of these
adopted a flatter morphology, and most of them exhib-cells was based exclusively on c-kit expression with no
ited signs of biochemical differentiation into the myo-negative selection for the blood cell lineages, the cells
genic, SMC, or EC lineage (see Experimental Proce-were uniformly negative for markers of the myeloid,
dures; Supplemental Figures S2A–S2D). At P0 (n  7),lymphoid, and erythroid lineages (CD34, CD45, CD20,
P3 (n  10), P10 (n  13), and P23 (n  13), myocytesCD45RO, CD8, and TER-119) (Kondo et al., 2003).
were 29%–40%, EC 20%–26%, SMC 18%–23%, and FThe phenotype of the cardiac c-kitPOS cells raises the
represented 9%–16%. At P0 and P1, when grown in DM,question of their origin. Clearly, they are different from
30% of the cells had detectable GATA-4 in the nucleusendothelial progenitor cells (EPCs) characterized from
and 55% expressed GATA-5; 50% were positive fordifferent species. EPCs, in addition to expressing c-kit,
Nkx2.5 and 60% for MEF2. Conversely, skeletal muscleare also positive for CD34, while the cells isolated from
(MyoD, myogenin, and Myf5), blood cell lineage (CD45,the myocardium are CD34 negative. The data available,
CD20, CD45RO, CD8, and snf TER-119) and neuralhowever, does not distinguish between intrinsic cardiac
(MAP1b, neurofilament 200, and snf GFAP) markerscells present in the myocardium since fetal life and cells
were not detectable (Supplemental Figures S3A–S3F).of extracardiac origin, perhaps from the bone marrow,
Cells tested at later passages (P19 and P26) exhibitedwhich have homed to the myocardium through the circu-
similar differentiation profiles.lation. CD45 expression has been considered as a
Despite the clear evidence of biochemical differentia-marker of hematopoietic origin for even the most primi-
tion in the main myocardial cell types, the phenotype oftive stem cells (Nadin et al., 2003). Because most c-kitPOS
the in vitro differentiated c-kitPOS cells was morphologi-cells of bone marrow origin are also positive for CD45
cally and functionally immature. Myocytes had a disor-and other blood lineage markers, the cells isolated here
ganized structure with no identifiable sarcomeres. Myo-either represent a different subpopulation or they have
cytes and SMC failed to contract spontaneously and inresided in the myocardium long enough to have lost the
response to angiotensin II, isoproterenol, norepineph-epitopes of the blood cell lineages.
rine, and electrical stimulation. EC did not express
eNOS. This spontaneous biochemical differentiation in
The Cardiac c-kitPOS Cells Are Self-Renewing, vitro falls short from progressing to a recognizable mor-
Clonogenic, and Multipotent, Giving Rise phological and functional differentiated phenotype.
to a Minimum of Three Different Despite the aborted differentiated phenotype, the very
Cardiogenic Cell Lineages high frequency of expression of biochemical markers
Freshly isolated c-kitPOS cells were plated in enriched specific for each of the three main myocardial cell types,
F12K medium (see Experimental Procedures) for 2–3 at each passage tested, is a strong indication of their
days, when most of the contaminating c-kitNEG cells self-renewal potential but does not address the issue
attached to the plastic while the c-kitPOS remained unat- of their apparent multipotentiality. The data cannot dis-
tached. The nonattached cells were transferred to modi- tinguish between the presence of a multipotent precur-
fied neural stem cell medium (mNSCM) lacking neuro- sor cell able to give rise to different cell types and a
genic factors (Tropepe et al., 1999). After 7–10 days in mixed culture containing two or more precursors, each
mNSCM, most cells attached and were continuously differentiating into one or two cell lineages. A clonal
grown for more than 1 year at subconfluent densities. analysis can distinguish between these alternatives.
Under these conditions, the cells maintained a stable To test the growth and differentiation potential of sin-
phenotype, most remained c-kitPOS, and had a doubling gle cells, clones were isolated by two different methods.
time of 40 hr. Cycling cells in culture, as determined For cloning by the dilution plating technique, c-kitPOS
by the expression of Ki67, ranged from 74%  12% to cells were first separated from the bulk of small cells of
84%  8% at passages (P)1–P5 and remained 72% at the dissociated myocardium by immunomagnetic beads
P23. Cells have continued to proliferate until the present and/or by FACS (see Experimental Procedures). The pu-
without reaching growth arrest or senescence more than rified population was seeded in 100 mm culture dishes
19 months after their isolation, as indicated by the dip- at a density of 100 cells per plate in mNSCM (Tropepe
loid chromosomal complement of 90% of the cells. et al., 1999). After 2–3 weeks, 156 small clones were
Cells frozen at P23 and thawed out 6 and 12 months obtained from a total of2,000 single cells. Fibronectin,
later have retained the characteristics of the original procollagen I, and vimentin were absent in 30 tested
clones, excluding fibroblast contamination (Supplemen-population.
Figure 3. Cloning, Growth, and Differentiation of c-kitPOS Cells
(A) Wells of a Terasaki plate with one sorted c-kitPOS cell (green) in each well. Left, phase contrast; right, epifluorescence.
(B–E) Clones in mNSCM shown by phase contrast.
(F) c-kitPOS clone (green). A few c-kit negative cells are visible.
(G–L) c-kitPOS cells (green) in DM express GATA-4 ([G], magenta, arrowheads; 45%  10%), Nkx2.5 ([H], white, arrowheads; 39%  8%),
MEF2C ([I], yellow, arrowheads; 36%  6%) and -sarcomeric-actin ([I], red, arrows; 27%  6%), cardiac myosin ([J], orange, arrows; 29% 
7%), -smooth-muscle-actin ([K], magenta, arrows; 21%  4%), and von Willebrand factor ([L], yellow, arrows; 17  4%). Bars: 100 m in
(B)–(F) and 10 m in (A) and (G)–(L).
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tal Figures S4A–S4F). These clones were also negative multipotent cells that have moved further along in the
for cytoplasmic markers of myocytes, SMC, and EC. Of differentiation pathway.
35 clones expanded in mNSCM, 31 grew successfully
and were expanded to mass cultures. The Cardiac-Derived LinNEG c-kitPOS Cells
A single, freshly isolated Lin c-kitPOS cell was placed Regenerate Functional Myocardium In Vivo
in each well of a 96-well Terasaki plate in mNSCM using The abortive differentiation in vitro of the isolated cells,
a cell sorter (see Experimental Procedures). From two their clones, and subclones suggested that DM was
separate platings of 5  103 cells each, not a single deficient in factors required for complete differentiation.
expandable clone was isolated. For this reason, freshly To determine whether these cells were capable of ac-
isolated Lin c-kitPOS cells were first allowed to recover quiring functional competence when properly stimu-
for 7–10 days in F12K enriched medium and for an addi- lated, we tested their ability to fully differentiate and
tional week in mNSCM. Cells were then sorted as above. reconstitute the myocardium when injected into the
Over 90% of the individual cells in the wells were c-kitPOS hearts of syngeneic rats acutely after myocardial in-
(Figure 3A) without nuclear or cytoplasmic signs of dif- farction. To this end, 1  105 cells at P2, grown in DM
ferentiation (not shown; see Experimental Procedures). supplemented with 1 mg/ml of BrdU replenished daily
Five different cell isolations from five rats were used for 6 days, were injected at each of two sites of the
to seed 1536 wells. 2–3 weeks later, 54 clones were border of a 5-hr-old infarct in two groups of animals.
collected. 25 of these clones, fixed and analyzed by Similarly, infarcted animals injected with equal volumes
immunocytochemistry, expressed c-kit (Figures 3B–3F) of PBS and sham-operated animals injected with the
and were negative for nuclear and cytoplasmic markers same number of cells as the experimental ones were
of biochemical differentiation (Experimental Proce- used as controls.
dures). Of the remaining 29 clones, 12 did not grow, Infarct size was determined at the time of sacrifice by
and the rest were expanded and frozen. All the clones comparing the number of spared myocytes in the left
analyzed were undifferentiated without lineage-commit- ventricle (LV) of control and experimental animals with
ted cells. those of the sham-operated animals in the same group,
Individual clones from both preparations (automated as determined by morphometry (see Experimental Pro-
cloning 17, dilution cloning 31) were characterized. cedures). Infarct size was 53%  7% and 49%  10%
In DM, 76% of the clones developed cells expressing (NS) of the LV in treated and untreated rats in the group
cytoplasmic markers specific for the cardiac lineages followed for 10 days, and 70%  9% and 55%  10%
as well as c-kitPOS cells expressing GATA-4, Nkx2.5, or (p  0.001) in treated and untreated rats in the 20 days
MEF2. Aggregates of small, spindle-shaped cells con- group, respectively. The differences in infarct size be-
taining nestin alone or nestin and other structural pro- tween control and experimental group is due, at least
teins were also present. c-kit was detected in early dif- in part, to the survival of animals with larger infarcts in
ferentiating myocytes, EC, and SMC (Figures 3G–3L). the treated as compared to the control groups.
Myocytes, SMC, and EC with a more advanced pheno- A band of BrdU-labeled regenerating myocardium
type were occasionally identified.
was found in 9 of 12 treated infarcts at 10 days and in
Cloned cells in mNSCM grew in suspension in bacteri-
all 10 treated infarcts at 20 days. At the early time point,
ological dishes and generated spherical clones (Figure
the regenerating band was thin and incompletely cov-
4A) similarly to other stem cells (Suslov et al., 2002).
ered the infarcted area but was thicker and presentSpheroids consisted of clusters of c-kitPOS and c-kitNEG
throughout the infarct at 20 days (Figures 5A–5F). Thecells surrounded by large amounts of nestin (Figures
total volume of the new myocardium generated at 104B–4D). They readily attached when transferred to cul-
and 20 days was 30 and 48 mm3, respectively. Thisture dishes and grown in DM; cells spread on the dish
regeneration had reduced infarct size from 53%  7%and differentiated (Figures 4E–4H).
to 40%  5% (p  0.001) in the 10 days group, andSubclones of primary clones confirmed the stability
from 70%  9% to 48%  7% (p  0.001) in the 20of the phenotype and further demonstrated their clono-
days group. At 10 days, the proportion of myocytes,genicity, self-renewal, and multipotentiality. The pheno-
capillaries, and arterioles was lower, and collagen wastype of most subclones was indistinguishable from that
higher than at 20. Cell growth evaluated by the fractionof the primary clones and produced myocytes, SMC,
of BrdU-positive cells expressing Ki67 was greater atand EC. In the cases tested, 80% of the cells had a
10 than at 20 days.diploid karyotype. However, 2 of 14 subclones (auto-
The regenerated myocardium was constituted bymated cloning six; dilution cloning eight) generated
BrdU-positive small myocytes, capillaries, and arteriolesonly myocytes and one only EC.
that appeared to mature over time. The myocytes ex-These results indicate that the Lin c-kitPOS cells iso-
pressed cardiac myosin heavy chain, -sarcomeric ac-lated from the adult myocardium are self-renewing, clo-
tin, -cardiac actinin, N-cadherin, and connexin 43 (Fig-nogenic, and multipotent. The progeny of single cells
ures 5D and 5E). At 10 days, the regenerating bandgives rise to the main myocardial cell types: myocytes,
contained 14  2.5  106 myocytes with a volume ofSMC, and EC (Supplemental Figures S5A–S5D). Thus,
1500  150 m3, while at 20 days the band had 13 these cells have the in vitro properties expected from
3  106 larger myocytes with an average volume ofmultipotent cardiac progenitor cells. However, given the
3,400  560 m3, as compared to the average volumeheterogeneity of the starting cell sample and the paucity
of 20,000–25,000 m3 for adult rat myocytes. While atof cell markers discriminating among developmental
10 days sarcomeres were rarely detectable in the smallstages of the myogenic pathway, it is not possible to
determine whether these cells are true stem cells or myocytes, at 20 days these cells were closely packed
Adult Cardiac Stem Cells and Cardiac Regeneration
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Figure 4. Proliferation and Differentiation of Clonogenic Cells in Spherical Clones
(A) Spherical clones in cell suspension.
(B) c-kitPOS cells (green, arrowheads) within the spheroid.
(C) Cell clusters in the spheroid surrounded by nestin (yellow).
(D) Accumulation of nestin (yellow) in spheroids.
(E) Cells in DM migrate out of the spheroid.
(F) Myocytes express cardiac myosin (red), (G) SMC, -smooth-muscle-actin (magenta), (H) EC, von Willebrand factor (yellow). Bars: 10 m
in (A)–(H).
with more abundant myofibrils and visible striations; cation of the injected cells measured here requires a
minimum of six to nine cell cycles, depending on theirN-cadherin and connexin 43, which define the fascia
adherens and nexuses in intercalated discs, were well survival rate at the injection site. The high frequency of
BrdU signal in the regenerating cells is in agreementdeveloped at the two time points. The degree of amplifi-
Cell
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Figure 5. Myocardial Repair
(A–E) Bands of regenerating myocardium in infarcted treated hearts at 20 days. (A) Sites of cell injection (arrows); (A–C) regenerated myocardium
(arrowheads). The rectangle in (A) is shown at higher magnification in (B). Cardiac myosin, red; PI, green. (D) Connexin 43 (yellow; arrows).
(E) N-cadherin (yellow; arrows). (D and E) BrdU-PI labeled nuclei, white-green.
(F) Scarring in a nontreated infarct. Collagen type I–III, blue. (B, C, and F) Asterisk indicates spared endomyocardium of infarcted LV.
(G–J) M mode tracings of untreated (G and H) and treated infarcted rats (I and J). (G and I) Baseline conditions before coronary artery occlusion.
(J) Reappearance of contraction at 19 days (arrowheads).
(K and L) Regenerating myocardium (green, arrowheads) at 10 days after injection of EGFP-clonogenic cells. The rectangle in (K) is shown at
higher magnification in (L). Asterisk indicates spared endomyocardium of infarcted LV.
(M) New myocytes within regenerating myocardium: cardiac myosin, red; EGFP, yellow-green; PI, blue.
(N and O) Arterioles, thin (N) and thick (O) walled: -smooth-muscle-actin, magenta; EGFP, yellow-green; PI, blue. Bars: 1 mm in (A) and (K);
100 m in (B), (C), (F) and (L); and 10 m in (D), (E), and (M)–(O).
with reports that in similarly labeled cells, BrdU can be tionally, the numerical density of capillaries and arteri-
oles increased from 10 to 20 days, paralleling the in-detected for up to 15 generations (Mahmud et al., 2001).
The plateau in myocyte number from 10–20 days was crease in cardiac tissue. At 10 days, there were 49 
11 arterioles and 595  103 capillaries per mm2 thatconsistent with a decrease in Ki67-expressing cells and
an increase in apoptosis (0.33%  0.23% to 0.85%  increased to 85  28 and 946  191 per mm2, respec-
tively, at 20 days. Thus, although arteriolar density has0.31%, p  0.001) between the two time points. Addi-
Adult Cardiac Stem Cells and Cardiac Regeneration
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Table 1. Effects of Myocardial Regeneration on Myocardial Performance
MI MI-T
SO 10 Days 20 Days 10 Days 20 Days
Echocardiography
Chamber diameter (mm) 5.4  0.4 7.4  0.6a 8.1  0.3a 6.6  0.5a,b 6.9  0.5a,b
Viable WT (mm) 1.11  0.11 0.78  0.08a 0.88  0.05a 0.87  0.11a 0.91 0.04a,b
Infarcted WT (mm) 1.03  0.14 0.46  0.11a 0.45  0.07a 0.56  0.06a 0.62 0.09a,b
Ejection fraction (%) 82  5 33  7a 34  3a 41  8a,b 45  10a,b
Hemodynamics
LV EDP (mmHg) 6.5  2.4 18.7  2.6a 18.8  3.3a 14.6  4.7a 10.5  6.3b
LV DP (mmHg) 107  5 68  12a 67  9a 77  12a 79  6a,b
LV 	 dP/dt (mmHg/s) 10870  1250 5350  520a 4830  570a 6400 250a,b 6410 980a,b
LV – dP/dt (mmHg/s) 9940  1200 4930  870 4590  440a 5730  470a 5470 740a,b
Wall stress (dynes/mm2) 100  64 590  130 560  100a 370  150a,b 270  160a,b
Regenerating myocardium (mm3) 30  5 48  6b
Data are present as mean  SD. Abbreviations: SO, sham-operated; MI, myocardial infarction; MI-T, myocardial infarction treated; WT, wall
thickness; LV, left ventricle; EDP, end diastolic pressure; and DP, developed pressure.
a Indicates a statistically significant difference from SO.
b Indicates a statistically significant difference from MI.
reached mature values (55–60/ mm2) in these animals, multipotent and capable of generating the three main
cardiac cell types. It is possible that the injected popula-capillary density is more comparable to the neonatal
tion is composed of a mixture of cells, with each having(1130/mm2) than the adult (4000/mm2) heart, even at the
a more restricted developmental potential. Also, despitelater time point. Taken together, these characteristics
the very significant expansion of the injected cells, thereinforce the conclusion that at 20 days, the regenerated
results do not provide a measure of the proliferativemyocardium resembles that of the neonatal heart.
potential of these cells. To gain a better insight on theseThe new myocardial cells positively affected cardiac
questions, 2  105 cells grown from a single clone inperformance. Contraction reappeared in the infarcted
mNSCM (dilution technique), genetically marked by aventricular wall (Figures 5G–5J). Cell implantation re-
retroviral vector expressing enhanced green fluorescentduced infarct size and cavitary dilation, increased wall
protein (EGFP), were locally injected in the border zonethickness, and ejection fraction. End-diastolic pressure,
of a 5-hr-old myocardial infarction in six rats, as above.developed pressure and dP/dt significantly improved at
10 days later, a band of newly formed myocardium was20 days. Diastolic stress was 52% lower in treated rats
identified in all six hearts. Most of the myocytes, SMC,(Table 1). Despite that treated surviving animals had
and EC in the regenerating bands expressed EGFP and,an infarct size 27% larger than controls, they had a
therefore, had originated from the injected cells. In gen-decreased diastolic load and improved overall pump
eral structure, size, and cellular composition thesefunction.
bands where indistinguishable from those obtained withClearly, after many doublings in culture, cardiac Lin
the mixed cell population.c-kitPOS cells remain differentiation competent and gen-
Cloning by dilution technique does not assure a singleerate myocytes, SMC, and EC when placed into a proper
cell origin of the clones harvested. For this reason, wecontext. The structure and cellular composition of the
tested two different clones and one subclone obtainedformed myocardial band are conclusive proof that these
by directly depositing single cells into wells containingcells rapidly replicate and differentiate when implanted
mNSCM (see Experimental Procedures) and harvestedinto the infarcted tissue. Proliferation is predominant at
from wells that we had ascertained by visual inspectionthe earlier time point while hypertrophy is prevalent later.
were seeded with a single EGFP-labeled cell. Each cloneInterestingly, the cells exhibited a tropism for the isch-
and the subclone were injected into two infarcted heartsemic zone because all the regenerating cells were lo-
each, as described above. 10 days after injection, allcated in the necrotic area and not in the spared myocar-
six animals had similar myocardial regenerating bandsdium despite the fact that cells were injected at the
(Figures 5K and 5L) composed of EGFP-positive myo-border between ischemic and healthy myocardium. The
cytes, arterioles, and capillaries (Figures 5M–5O). Thesestimulating role of ischemia is highlighted by the rapid
regenerating bands were not distinguishable from eitherdisappearance of the BrdU-labeled cells when injected
those produced by the dilution technique clones or theinto healthy hearts of mock-infarcted animals (not
mixed cell population.shown).
From these three independent myocardial regenera-
tion assays, it is fair to conclude that Lin c-kitPOS cells
The Cardiac Lin c-kitPOS Cells isolated from the adult rat heart behave in vivo like stem
Are Multipotent In Vivo cells since they are self-renewing, clonogenic, and
The in vivo results described above do not address multipotent. Their proliferation potential is very robust
whether the Lin c-kitPOS cells injected, although able to since the progeny of a single cell can, at a minimum,
regenerate two functional ventricular walls, each com-regenerate a functional ventricular wall, are truly
Cell
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Figure 6. Myocyte Mechanics
(A–E) Regenerated BrdU-positive myocytes ([A], [B], [D]; green dots in blue nuclei, arrowheads), connexin 43 ([B] and [C]; yellow, and N-cadherin
([D] and [E]; yellow). Bars: 10 m in (A)–(E).
(F–H) Small new and large spared myocytes (F) in treated rats. Sarcomere mechanics in a new (G) and a spared (H) myocyte.
posed of 14  106 myocytes and approximately two c-kitPOS cells generate bona fide cardiac myocytes from
a structural and functional point of view.to three times as many of the other cell types.
The Myocytes Produced by the Cardiac Lin The Regenerating Myocytes Are Not the Result
of Cell Fusion between Injected Cellsc-kitPOS Cells Are Structurally
and Functionally Competent and Spared Myocytes
The purported plasticity and multipotency of some stemThe improved functional performance of the postin-
farcted hearts injected with Lin c-kitPOS cells is strongly cells, such as those from the bone marrow, and their
capacity to differentiate into cell types other than thosesuggestive that the newly generated myocytes are func-
tional and contribute to the overall contractility of the of their tissue of origin, as reported by us and many
others, has been thrown into doubt by the recent demon-treated hearts. This point of view is further supported by
the reappearance of synchronous motility of the treated stration that under some situations certain stem cells
have a tendency to fuse in vitro and with the differenti-ventricular wall as detected by echocardiography. Yet,
none of these parameters conclusively proves that the ated cells of the host organ in vivo (see Alison et al.,
2003; Rosenthal, 2003). This phenomenon can give thegenerated myocytes have normal contractile properties.
Therefore, to unambiguously determine whether these appearance of transdifferentiation when in reality only
hybrid cells are exhibiting the differentiated phenotype.myocytes are truly functional, they were isolated at 20
days after injection. As shown in Figures 6A–6E, the Although the results described here do not address the
issue of transdifferentiation because cells of cardiacBrdU-labeled myocytes had their myofibrillar proteins
mostly distributed at the periphery of the cell in the origin are shown to differentiate into cardiac cell types, it
is still necessary to determine whether the regeneratingsubsarcolemmal region, with visible sarcomeric stria-
tions in a pattern very similar to fetal and neonatal myocytes, expressing the biochemical tags specific of
the injected cells, could have originated by the fusioncardiocytes. N-cadherin and connexin 43 are located at
the expected position for myocytes that are functionally of a donor cell with a spared myocyte instead of under-
going true lineage commitment.integrated and electrically and mechanically coupled.
Figures 6F–6H compare the contractility parameters Five lines of evidence conclusively argue against cell
fusion as a biologically significant phenomenon for theof the new cells with those of the spared myocytes.
Despite the dramatic size difference between new and observations described here, although we cannot rule
out that a very small fraction of new myocytes are pro-surviving myocytes, they exhibit similar time to peak
shortening, with higher values of peak shortening and duced by cell fusion. (1) The number of new myocytes
is orders of magnitude higher than the injected cells,velocity of shortening for sarcomeres of the new myo-
cytes. These data clearly establish that in vivo, the Lin which in addition also give rise to SMC and EC. (2)
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The myocardial infarct model used here leaves very few nately, these assays are not possible in most solid or-
gans and particularly in the heart where the tested cellsspared myocytes in the necrotic area, and those are
mainly located in the subendo- and/or subepicardium have no selective advantage. If judged by the criteria
mentioned above, our data fall short of establishing the(see Figures 5B and 5C), while the regenerating myo-
cytes are mainly located in the center of the wall. (3) No stem cell nature of the cardiac Lin c-kitPOS cells. More-
over, because we have not yet identified antigenic mark-small myocytes with the biochemical tags of the injected
cells (BrdU or EGFP) are found in the spared myocar- ers to follow the progression of these cells along the
cardiac lineages, we cannot distinguish between truedium where differentiated fusion partners are in great
abundance. (4) The size of newly formed myocytes at the stem, amplifying, and progenitor cells. Yet, given the
limitations of the biology of this organ, the cloning andstages analyzed here is more than an order of magnitude
smaller than that of the spared myocytes (see Figure subcloning of these cells, their in vitro and in vivo pheno-
type, together with the organ regenerative capacity ex-6F), while the product of cell fusion would be expected
to be at least as large as the differentiated partner. (5) hibited by the progeny of a single cell make a convincing
argument that these cells have the characteristics ex-Regenerating myocytes have a 2n DNA content and not
the 4n expected for fusion products as determined pected of a cardiac stem cell and/or their immediate
progeny.from the analysis of four different cell preparations in
which the DNA content of cycling (Ki67 positive) and
noncycling (Ki67 negative) myocytes was determined Origin and Nature of the Resident
using lymphocytes as controls. In all cases,99% of the Cardiac Stem Cells
noncycling myocyte population had a 2n DNA content. One of bewildering findings of the past few years has
Higher values were always associated with cycling lym- been the variety of cell types that under different experi-
phocytes and myocytes (not shown). mental conditions have shown the capacity to give rise
From these data, we conclude that the regenerating to cardiac myocytes. In addition to the cells reported
myocytes result from proliferation and differentiation of here, cardiogenic potential has been demonstrated for
the injected cardiac Lin c-kitPOS cells and not from bone marrow cells—presumably Lin c-kitPOS—cells mo-
cell fusion. bilized with the systemic administration of cytokines,
human mesenchymal stem cells, liver-derived stem
cells, endothelial cells, cells from the embryonic dorsalDiscussion
aorta, and multipotent adult progenitor cells (MAPCs)
from the bone marrow (see Nadal-Ginard et al., 2003).The Adult Heart Contains Undifferentiated Cells
Surprisingly, the markers used to identify these “cardio-with the Characteristics of Cardiac Stem Cells
genic” cells are very different and at times mutuallyThe results presented here document the existence in
exclusive. While the bone marrow (Orlic et al., 2001) andthe adult rat heart of a population of Lin c-kitPOS cells
the cardiac cells used here were isolated using c-kit asthat in vitro and in vivo exhibit all the properties expected
a marker, lack of expression of this receptor is one offor cardiac stem cells. They are self-renewing, clono-
the identifying characteristics of the MAPCs (Jiang etgenic, and multipotent, giving rise to a minimum of three
al., 2002). Other confounding aspects of the data aredifferentiated cell types: myocytes, smooth muscle, and
that the identity of the myocardium-generating cells hasendothelial vascular cells. Moreover, when injected into
only been established in a few cases by the use of singlean ischemic heart, a population of these cells or the
cells or their progeny (this work; Krause et al., 2001;clonal progeny of one of them reconstitute a well-differ-
Jiang et al., 2002) and, with the exception of this report,entiated myocardial wall that encompasses up to 70%
the differentiated phenotype remains functionally un-of the LV. This regenerated ventricular wall is constituted
characterized.by blood carrying new vessels and myocytes that, al-
The origin of the Lin c-kitPOS cells is not known. Datathough smaller in size, have the anatomical, biochemi-
from the sex-mismatched heart transplants (Quaini etcal, and functional properties of young myocytes. To
al., 2002) show that cells of recipient origin with similarthe best of our knowledge, this is one of the most exten-
characteristics reach the transplanted heart and differ-sive solid organ tissue regenerations using stem cells
entiate into the three types of cardiac cells in a matterreported so far. In a matter of a few weeks, the injected
of days. These cardiac cells, however, are different fromcells regenerate more than 50% of the contractile myo-
circulating EPCs, which are CD45	, CD34	, and partici-cytes and vascular cells normally present in the myo-
pate in the regeneration of smooth muscle and endothe-cardium.
lial cells, but not myocytes (see Nadal-Ginard et al.,Over the past 2 years, a high level of skepticism has
2003). If the cardiogenic cells presented here reachedmet many claims on the behavior of adult stem cells,
the myocardium through the circulation, then they haveparticularly their multipotency and transdifferentiation
resided in the myocardium long enough to adopt theirproperties (see Alison et al., 2003; Rosenthal, 2003).
specific phenotype, because no cells with their charac-Also, there have been attempts to establish criteria for
teristics have been identified in the bone marrow orthe analysis of the developmental potential of putative
peripheral circulation.adult stem cells (Anderson et al., 2001) modeled on
the known behavior of hematopoietic stem cells. These
criteria require tracking and phenotyping the progeny Cardiac Organogenesis versus
Cardiac Regenerationin vivo of a single putative stem cell that has not been
cultured in vitro and documenting the stability of the During cardiac development, the myocyte lineage is de-
rived from the cardiogenic plates, which differentiatephenotype by successive passages in vivo. Unfortu-
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into contractile cells that rapidly divide until the perinatal Prospects for Myocardial Regeneration
Despite the significant advances over the past two de-stage. Coronary vasculature does not appear until later
cades in the management of human acute myocardialin development. Cell lineage marking experiments dur-
infarction, there remains a large population of postin-ing cardiogenesis in the chicken, zebrafish, and mam-
farct survivors who will develop cardiac failure, leadingmals show that myocytes, SMC, and EC originate each
to early death (Hellermann et al., 2002). Cardiac trans-from a separate lineage (see Mikawa, 1999). This devel-
plantation remains the only therapy available to theseopmental pattern contrasts with the pluripotent nature
patients. Because of the ingrained concept of the myo-of the cardiac Lin c-kitPOS cells, which produce myo-
cardium as a terminally differentiated organ, it has beencytes and vascular cells both in vitro and in the ischemic
assumed that any attempt to replace the lost myocytesmyocardium. Because the lineage marking experiments
using cellular therapy would require the introduction ofdo not test the developmental potential of the cells
exogenous cells into the myocardium. Recently, theretracked, the different outcomes might represent another
has been a flurry of reports of human myocardial therapyexample of the differences between normal develop-
using bone marrow cells (Strauer et al., 2002; Assmusmental fate and developmental potential. Alternatively, it
et al., 2002; Tse et al., 2003; Perin et al., 2003) based,is possible that cardiogenesis and cardiac regeneration
in part, on our early results with myocardial regenerationmight result from distinct differentiation programs, as is
with bone marrow derived cells (Orlic et al., 2001). Thethe case of Wolffian regeneration where a new lens is
demonstration that the heart harbors stem cells capableformed from the iris, while the original lens is formed
of regenerating large amounts of functional myocardiumfrom the epidermis (Kosaka et al., 1998). Experiments
explains our earlier observation of a robust regenerativeto distinguish between these alternatives and elucidate
response in the acute postinfarct (Beltrami et al., 2001)the origin of the adult cardiogenic cells are in progress.
while raising the question of why this regenerative re-
sponse stops before the completion of the repair. At the
same time, the identification of these cells opens theThe Adult Heart Is Not a Terminally
tantalizing possibility that they might be coached in vivoDifferentiated Organ
to home within the damaged myocardium, subsequentlyDespite the increasing body of data documenting the
promoting functional cardiac repair without the need offormation of new cardiac myocytes in the adult normal
introducing exogenous cells. The extraordinary clinical
and diseased mammalian heart, the idea that normal
potential of myocardial regeneration makes the dissec-
and pathological cardiac homeostasis involves myocyte
tion of the biology of these cardiac stem cells a challeng-
cell death and renewal has met with significant resis-
ing and exciting endeavor.
tance in the cardiovascular community. This resistance
has been due to the fact that until now, there has been Experimental Procedures
a lack of biological understanding about the origin and
fate of the cycling myocytes detected in the normal and c-kitPOS Cells
Cardiac cells were isolated from female Fischer rats at 20–25 monthspathological heart. The existence of myocardial stem
of age, and myocytes were discarded. Small intact cells were resus-cells capable of committing to the myogenic lineage
pended and aggregates removed with a strainer. Cells were incu-conclusively dispels the notion of the heart as a termi-
bated with a rabbit c-kit antibody (H-300, Santa Cruz) (Broudy, 1997).
nally differentiated organ without self-renewal potential c-kitPOS cells were collected with magnetic beads (Dynal) coated
and provides an explanation, as well as a biologically with anti-rabbit IgG (n 13). For FACS (n 4), cells were stained with
r-phycoerythrin-conjugated rat monoclonal anti-c-kit (Pharmingen).satisfactory context, for the existence of the cycling
Purity of sorted cells was determined by FACS.myocytes. The finding of c-kitPOS cells that have already
activated the myogenic program in situ, their capacity
Cell Culture and Cloningto generate a progeny of millions of myocytes when
c-kitPOS cells were plated for 5–7 days at 1–2  104 cells/ml F12K
injected into the ischemic myocardium as reported here, medium containing 5% FCS, bFGF, and LIF. After recovery, they
together with the small size of the cycling myocytes in were moved to mNSCM (Tropepe et al., 1999) without heparin and
the normal, pathological, and regenerating heart indi- neurotrophic growth factors: Dulbecco’s MEM and Ham’s F12 (ratio
1:1), bFGF (10 ng/ml), EGF (20 ng/ml), LIF (10 ng/ml), HEPES (5cates that these cycling cells are the progeny of the
mM), and insulin-transferrin-selenite. For cloning by plating dilutioncardiac stem or amplifying cells that have not yet
technique, cells were seeded at 1-5 cells/cm2 in mNSCM. For cloningreached a mature and terminally differentiated state.
by plating dilution technique, cells were seeded at 1–5 cells/cm2 in
Long-term labeling and chase experiments suggest that mNSCM. After one week, individual colonies were collected with
once committed to the myocyte lineage the progeny of cloning cylinders and plated. One clone from each preparation was
chosen for characterization. MEM containing 10% FCS and 108 Ma stem cell can undergo three to four rounds of cell
dexamethasone was employed to induce differentiation (DM). Fordivision before permanently withdrawing from the cell
subcloning, cells from a clone were plated at 1–5 cells/cm2 incycle (A.L., unpublished). All these data strongly suggest
mNSCM. At each subcloning step, an aliquot was grown in suspen-
that throughout adult life, the stem cells characterized sion to develop clonal spheres.
here regenerate the myocytes lost by the normal wear In a separate experiment, single cell cloning was employed. Iso-
lated c-kitPOS cells were collected with Miltenyi immunomagneticand tear and go on overdrive in response to significant
microbeads (n  5). Before sorting, bead-coated cells were treatedmyocyte loss. Thus, the adult heart, which like the brain
first in enriched F12K medium and then in mNSCM for 5–7 days(Gage, 2002) is composed of mainly terminally differenti-
each. Subsequently,20,000 cells were sorted (MoFlo High Perfor-
ated parenchymal cells that do not reenter the cell cycle, mance Cell Sorter, Cytomation), and single cells were deposited in
is not a terminally differentiated organ because it also Terasaki plates. The individual cells were grown in F12K medium
for 1–2 weeks when clones were identified and expanded. Clono-contains stem cells that support its regeneration.
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genic cells were then grown in mNSCM for an additional week before Statistics
Results are mean  SD. Significance (p  0.05) was determined byplating in DM or retroviral infection in mNSCM.
Student’s t test and Bonferroni method.
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